OWNING THE BUSINESS VS. PRACTICING THE MEDICINE: WHAT ACTUALLY SEPARATES THEMThe single question that stops most serious buyers is usually asked in a form that has no answer — here is the shape of the real question, and who has to answer it for you.

Educational overview · Approx. 9 min read · illustrative, not advice

The single question that stops most serious buyers is usually asked in a form that has no answer — here is the shape of the real question, and who has to answer it for you.

The Fear That Stops Serious Buyers Cold

Nearly everyone who looks hard at a cash-pay metabolic business arrives at the same sentence inside the first ten minutes: I'm not a physician, so this probably isn't available to me. It is a reasonable instinct and a badly formed question, because it fuses two separate legal objects — owning a business and practicing medicine — into one thing that does not exist as a single item anywhere.

Nobody can answer "can I own a GLP-1 clinic" in an article, and you should distrust any page that tries. The governing rules are state-level, they differ in substance rather than merely in wording, and several states moved on them during 2025. What an article can honestly do is show you the shape of the question, so that when you sit down with a healthcare attorney licensed in your own state you are paying for answers instead of paying for an education.

Atlas Metabolic is not a law firm and this is not legal advice. Every specific below is deliberately written as a question for your counsel rather than as a statement about what is or is not permitted where you live. That framing is not throat-clearing; it is the actual state of the world.

Two Objects, Two Entirely Different Sets of Rules

A business entity — an LLC, a corporation — comes into existence through a state filing and is owned by whoever holds its equity. A medical license is something else in kind: it is issued to a human being by a state board, it is exercised through that person's clinical judgment, and it cannot be transferred, delegated to a non-clinician, or acquired in an asset purchase. Confusing the two is what produces the impossible question.

Almost everything a metabolic wellness business does falls cleanly on one side of that line. Member acquisition, brand, pricing of non-clinical services, scheduling and technology, supply relationships, real estate, non-clinical staffing, data and reporting, capital structure — business. Evaluating a member's history, deciding whether a prescription is appropriate at all, selecting an agent and dose, monitoring, and deciding when to stop — clinical, and the property of a separately licensed medical entity and the clinicians inside it.

The split is not cosmetic, and it drives model selection long before it drives paperwork. If you have not yet worked through where the delivery actually happens, the comparison of a bricks-and-mortar build against a distributed one in our piece on the clinic versus digital model is the right prerequisite, alongside what independent clinic ownership means in practice.

Why the Corporate Practice of Medicine Doctrine Exists at All

The reason this line is policed rather than assumed is a body of state law usually called the corporate practice of medicine doctrine. Per a 2025 Milbank Memorial Fund issue brief, it consists of state-level rules barring unlicensed persons and corporations from owning or controlling medical practices or employing physicians for clinical care, with the stated purpose of preserving independent medical judgment. The concern it encodes is narrow and specific: who is permitted to overrule a clinician.

Its reach varies by state. You will find secondary sources confidently announcing that roughly thirty-odd states have such laws; the methodology behind those counts is inconsistent and the Milbank brief itself declines to state a number. We will not repeat a count we cannot stand behind. Treat the doctrine as varying materially by jurisdiction and get your own state read.

Direction of travel matters more than any headcount. Milbank reports that in 2025 Massachusetts enacted management-services-organisation ownership transparency requirements, and that CPOM-strengthening bills were introduced in Oregon, Washington and California. Scrutiny is tightening, not loosening. Anyone designing a structure intended to last five years should assume the rules get more demanding rather than less.

What a Management Services Organisation Is Actually For

The standard structural answer, described in the same Milbank brief, is separation: a clinician-owned professional corporation holds the clinical side, and a management services organisation handles non-clinical functions under a written agreement. That is the architecture almost every serious operator in this category is either using or being asked about.

It is not a magic word. Milbank is explicit that enforcement risk turns on the degree of control the MSO exercises over clinical operations and professional judgment — not on whether the boxes on the org chart are drawn in the right places. A structure that formally separates the entities while functionally letting the business decide who gets a prescription is the failure case the doctrine exists to catch.

Because this is where most of the serious buyer questions land, it has its own page. Read how a management services organisation is used in medical weight loss for the mechanics — what a management services agreement typically covers, and the fee-splitting questions that go with it — then bring the specifics to counsel.

Clinical Independence Is Structural, Not Decorative

Two things follow from taking independence seriously. The first is that the clinical entity has to be genuinely capable of saying no — declining a member, declining a renewal, declining a dose — without a commercial override. A model whose economics only work if nobody is ever turned away is not a compliance problem waiting to happen; it is one already.

The second is geography. Medical practice is generally deemed to occur where the patient is located, which means a clinician typically must be licensed in the patient's state; the Interstate Medical Licensure Compact provided a streamlined multi-state pathway covering up to 43 member states as of March 2026. That single fact reshapes any plan for serving members beyond one metro, and it is the hinge in the trade-off we lay out in telehealth versus in-clinic metabolic care.

Note what changes and what does not. A telehealth-first or hybrid approach shifts the composition of cost — it avoids build-out and clinical equipment lines while adding multi-state licensure and technology lines — rather than reducing a total. That is an inference about composition, not a claim about magnitude, and certainly not a claim about what any operator ends up spending.

The Costs That Ride With the Clinical Side

Some line items attach to the clinical license rather than to the business, which is precisely why they surprise people who budgeted only for the business. Practitioner registration with the DEA is $888 per three-year registration period under 21 CFR 1301.13 — small, fixed, and easy to verify yourself.

Liability insurance is the one that moves. The American Medical Association, publishing in May 2026 from Medical Liability Monitor rate survey data, reported that medical liability premiums rose for a seventh consecutive year, with the share of reported premiums increasing year over year climbing from 13.7% in 2018 to nearly 40% in 2025 — the highest share since 2005. The same reporting lists a 2025 internal medicine manual premium of $59,736 in Miami-Dade County, Florida, against $243,988 for ob-gyn and general surgery in that market. Read Miami-Dade as a high-cost outlier, not a national baseline.

Beyond those, published startup ranges for medical practices circulate widely — roughly $70,000 to $500,000 in the first year, with build-out, equipment and IT components — but we could not trace the survey attribution that usually accompanies them, so we label the whole set an inference rather than a fact. Cost figures also travel alone here: no revenue number accompanies them and none may be derived from them. For how we think about the structural cost side generally, see the walk-through of unit economics in metabolic care and the franchise cost comparison.

The Questions to Put In Front of Your Own Counsel

Take this list to a healthcare attorney licensed in the state where members will be located. The value of the list is that it is specific enough to bill against.

• How does this state treat ownership and control of a medical practice, and what has changed in the last twenty-four months?
• If a professional entity and a management entity are used, what does this state's law and enforcement history say about the degree of control the management side may exercise?
• What must a management services agreement contain, and what must it never contain, for it to survive scrutiny here?
• How is the management fee permitted to be calculated, and what fee-splitting or fraud-and-abuse rules bear on that answer? Do not assume a cash-pay model sits outside every rule — ask.
• Which clinician licensures and registrations are required in each state where members will actually be located, and what does the compact pathway change?
• Who owns the member relationship, the records, the brand and the data, and does anything in this state's rules constrain that?
• What happens to the structure if the clinical entity's owner leaves, dies, or is disciplined?

What Atlas Does, and What Atlas Never Does

Atlas Metabolic provides no medical services and employs no clinicians. Atlas licenses a business build — telehealth stack, ordering system, member coaching technology, brand kit and operational playbooks — to a partner. Clinical care in any Atlas-built business is delivered by a separately licensed medical entity that is clinically independent, and Atlas neither directs nor participates in clinical decisions. That is not a disclaimer bolted on at the end; it is the reason the two sides of the build are documented separately in how the build works and in our compliance position.

Ask Atlas to put this in writing: whether Atlas introduces partners to independent medical entities in a given market, or the partner sources and contracts that relationship independently

The commercial terms are deliberately simple and deliberately not a percentage of anything: a one-time license fee, 0% of revenue, no ongoing partner fees. The license fee is one-time. It carries 0% of revenue and no ongoing partner fees. The figure is not published anywhere, by design — it is disclosed in full on the fit call, where it can be put next to what it covers instead of floating on its own. If your instinct is to compare that against a royalty model, the arithmetic of how a gross royalty actually compounds and the plain-English reading of FDD Item 6 are the two pages to read before any call.

How the Decision Actually Gets Made

The honest close is that this page cannot qualify you and neither can a form. What it can do is tell you what to resolve before you spend money: whether you intend to own a business or practice medicine, who your healthcare counsel is, and which state's rules you are actually operating under.

Atlas takes a limited number of partner builds — Ask Atlas to put this in writing: partner slots per quarter — and the fit call decides in both directions. Some of the most useful calls we have end with us saying no, or with a candidate deciding the model is not what they wanted. Work through the diligence questions first if you want the call to be short and useful, then submit the partner application. Bring your counsel's questions with you; we would rather answer them on the record than watch you guess.

FREQUENTLY ASKED QUESTIONS.